Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Annals of Oncology[TA])
11,322 results
  • Overall Survival and Risk of Second Malignancies with Cancer Chemotherapy and G-CSF Support. [Journal Article]
  • AOAnn Oncol 2018 Aug 07
  • Lyman GH, Yau L, … Krendyukov A
  • CONCLUSIONS: Our findings demonstrate that overall survival is improved in patients receiving intensified chemotherapy with primary G-CSF support, compared to those receiving standard chemotherapy. Primary G-CSF support was also associated with a higher risk of developing secondary malignancies, including secondary acute myeloid leukemia and myelodysplastic syndrome.
New Search Next